4//SEC Filing
Young Joseph R 4
Accession 0001415889-24-001518
CIK 0001831828other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:06 PM ET
Size
7.7 KB
Accession
0001415889-24-001518
Insider Transaction Report
Form 4
Young Joseph R
SVP, FINANCE, CHIEF ACCT OFFCR
Transactions
- Award
Class A Common Stock
2024-01-16+21,875→ 57,054 total - Award
Stock Option (right to buy)
2024-01-16+81,250→ 81,250 totalExercise: $16.80Exp: 2034-01-15→ Class A Common Stock (81,250 underlying)
Footnotes (3)
- [F1]Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service through each vesting date.
- [F2]Includes 2,500 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on September 13, 2023.
- [F3]1/48 of the shares subject to the stock option will vest and become exercisable on February 16, 2024, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001861684
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:06 PM ET
- Size
- 7.7 KB